Prognostic significance of NGAL in early stage chronic kidney disease

Creative Commons License

Basturk T., Sari O., Koc Y., Eren N., Isleem M., Kara E., ...Daha Fazla

MINERVA UROLOGICA E NEFROLOGICA, cilt.69, sa.3, ss.307-312, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 69 Sayı: 3
  • Basım Tarihi: 2017
  • Doi Numarası: 10.23736/s0393-2249.16.02770-3
  • Dergi Adı: MINERVA UROLOGICA E NEFROLOGICA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.307-312
  • Anahtar Kelimeler: Lipocalin-2, Biomarkers, Renal insufficiency, chronic, GELATINASE-ASSOCIATED LIPOCALIN, RENAL-FUNCTION, CYSTATIN C, SERUM, MARKER, BIOMARKERS, CREATININE
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

BACKGROUND: Neutrophilgelatinase-associated lipocalin (NGAL) has been proven to be a useful biomarker for early detection of acute kidney injury, but it is not known whether adding NGAL measurements to conventional risk factors will improve the risk assessment in the setting of chronic kidney disease (CKD). The aim of the present study was to examine the correlation of NGAL with early stage renal impairment in CKD and to evaluate its prognostic value in these subjects.